Previous studies have demonstrated that T cell–reactive antibodies in HIV-1 infection contribute to lymphocyte depletion by cytotoxicity that involves differential membrane targets, such as the 43.5-kD receptor on CEM cells. Here, we show that these antibodies bind Fas as result of a molecular mimicry of the gp120. Both flow cytometry and immunoblotting using the human Fas-transfected mouse WC8 lymphoma revealed positive binding of immunoglobulin G from several patients to a 43.8-kD membrane receptor that also reacts with the CH11 anti-Fas monoclonal antibody. Specificity to Fas was further confirmed to chimeric recombinant human Fas-Fc by ELISA, whereas overlapping peptide mapping of a Fas domain (VEINCTR–N) shared by gp120 V3 loop demonstrated a predominant affinity to the full-length 10-mer peptide. Four anti-Fas affinity preparations greatly increased the subdiploid DNA peak of CEM cells similar to agonist ligands of Fas. In addition, anti-Fas immunoglobulin G strongly inhibited the [3H]thymidine uptake of CEM cells in proliferative assays, inducing a suppression as high as provoked by both CH11 mAb and recombinant human Fas ligand. Since anti-Fas were reactive to gp120, it is conceivable that antibodies binding that domain within the V3 region are effective cross-linkers of Fas and increase apoptosis in peripheral T cells. These results suggest that autologous stimulation of the Fas pathway, rather than of lymphocytotoxic antibodies, may aggravate lymphopenia in a number of HIV-1+ subjects.
Skip Nav Destination
Article navigation
1 December 1996
Article Contents
Article|
December 01 1996
Cross-linking of Fas By Antibodies to a Peculiar Domain of gp120 V3 Loop Can Enhance T Cell Apoptosis in HIV-1–infected Patients
Franco Silvestris,
Franco Silvestris
From the *Department of Biomedical Sciences and Human Oncology, University of Bari, Section of Internal Medicine, 70124 Bari, Italy; and ‡Department of Molecular Biology, Osaka Bioscience Institute, Osaka 565, Japan
Search for other works by this author on:
Shigekazu Nagata,
Shigekazu Nagata
From the *Department of Biomedical Sciences and Human Oncology, University of Bari, Section of Internal Medicine, 70124 Bari, Italy; and ‡Department of Molecular Biology, Osaka Bioscience Institute, Osaka 565, Japan
Search for other works by this author on:
Paola Cafforio,
Paola Cafforio
From the *Department of Biomedical Sciences and Human Oncology, University of Bari, Section of Internal Medicine, 70124 Bari, Italy; and ‡Department of Molecular Biology, Osaka Bioscience Institute, Osaka 565, Japan
Search for other works by this author on:
Nicola Silvestris,
Nicola Silvestris
From the *Department of Biomedical Sciences and Human Oncology, University of Bari, Section of Internal Medicine, 70124 Bari, Italy; and ‡Department of Molecular Biology, Osaka Bioscience Institute, Osaka 565, Japan
Search for other works by this author on:
Franco Dammacco
Franco Dammacco
From the *Department of Biomedical Sciences and Human Oncology, University of Bari, Section of Internal Medicine, 70124 Bari, Italy; and ‡Department of Molecular Biology, Osaka Bioscience Institute, Osaka 565, Japan
Search for other works by this author on:
Franco Silvestris
,
Shigekazu Nagata
,
Paola Cafforio
,
Nicola Silvestris
,
Franco Dammacco
From the *Department of Biomedical Sciences and Human Oncology, University of Bari, Section of Internal Medicine, 70124 Bari, Italy; and ‡Department of Molecular Biology, Osaka Bioscience Institute, Osaka 565, Japan
Address correspondence to Prof. Franco Silvestris, M.D., DIMO, Section of Internal Medicine, P.za Giulio Cesare, 11, 70124 Bari, Italy.
1Abbreviations used in this paper: aa, amino acid; CDC, Center for Disease Control and Prevention; PI, propidium iodide; RF, rheumatoid factor; rFas-L, recombinant human Fas ligand.
Received:
March 08 1996
Revision Received:
September 11 1996
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1996
J Exp Med (1996) 184 (6): 2287–2300.
Article history
Received:
March 08 1996
Revision Received:
September 11 1996
Citation
Franco Silvestris, Shigekazu Nagata, Paola Cafforio, Nicola Silvestris, Franco Dammacco; Cross-linking of Fas By Antibodies to a Peculiar Domain of gp120 V3 Loop Can Enhance T Cell Apoptosis in HIV-1–infected Patients. J Exp Med 1 December 1996; 184 (6): 2287–2300. doi: https://doi.org/10.1084/jem.184.6.2287
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement